|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1



* Division of Endocrinology, Diabetes and Hypertension, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Unité de Recherche sur les Mécanismes de la Résorption Osseuse (Université de Picardie) et INSERM ERI-12, Amiens, France; and
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
1Correspondence: Unité de Recherche sur les Mécanismes de la Résorption Osseuse et INSERM, ERI-12, 1 rue des Louvels, 80037 Amiens, France. E-mail: romuald.mentaverri{at}sa.u-picardie.fr
ABSTRACT
Intracellular transduction pathways that are dependent on activation of the CaR by Cao2+ have been studied extensively in parathyroid and other cell types, and include cytosolic calcium, phospholipases C, A2, and D, protein kinase C isoforms and the cAMP/protein kinase A system. In this study, using bone marrow cells isolated from CaR/ mice as well as DN-CaR-transfected RAW 264.7 cells, we provide evidence that expression of the CaR plays an important role in osteoclast differentiation. We also establish that activation of the CaR and resultant stimulation of PLC are involved in high Cao2+-induced apoptosis of mature rabbit osteoclasts. Similar to RANKL, Cao2+ (20 mM) appeared to trigger rapid and significant nuclear translocation of NF-
B in a CaR- and PLC-dependent manner. In summary, our data suggest that stimulation of the CaR may play a pivotal role in the control of both osteoclast differentiation and apoptosis in the systems studied here through a signaling pathway involving activation of the CaR, phospholipase C, and NF-
B.Mentaverri, R., Yano, S., Chattopadhyay, N., Petit, L., Kifor, O., Kamel, S., Terwilliger, E. F., Brazier, M., Brown, E. M. The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis.
This article has been cited by other articles:
![]() |
J. E. Fonseca Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength Rheumatology, July 1, 2008; 47(suppl_4): iv17 - iv19. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, W. Chen, P. Stashenko, and Y.-P. Li Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation J. Cell Sci., October 1, 2007; 120(19): 3362 - 3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Dvorak, T.-H. Chen, B. Orwoll, C. Garvey, W. Chang, D. D. Bikle, and D. M. Shoback Constitutive Activity of the Osteoblast Ca2+-Sensing Receptor Promotes Loss of Cancellous Bone Endocrinology, July 1, 2007; 148(7): 3156 - 3163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |